Assyro AI

FDA Orange Book · active-ingredient family

Technetium tc-99m tilmanocept

Technetium tc-99m tilmanocept is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:LYMPHOSEEK KIT · NDA 202207

1

Brand (NDA)

0

Generics (ANDA)

1

Listed patents

0

Exclusivity periods

Brand (NDA) products · injectable

ProductApplicantApplicationTEApproved
LYMPHOSEEK KITRLDCARDINAL HEALTH 414NDA 202207Mar 13, 2013

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
9439985Jan 30, 2029in 2 yr 8 mo
Product

Technetium tc-99m tilmanocept — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.